Avantor Q4 Earnings Up, Despite Lower Sales

Avantor (NYSE:AVTR) Misses Q4 Sales Targets, Stock Drops
Life sciences company Avantor (NYSE:AVTR) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 2.1% year on year to $1.69 billion. Its non-GAAP profit of $0.27 per share was 4.
Avantor Q4 Earnings Up, Despite Lower Sales; Stock Slides In Pre-market
Avantor, Inc. (AVTR), a biotechnology, chemicals, and pharmaceuticals company, Friday announced a surge in net income for the fourth
Avantor Q4 Earnings Report: What Investors Need to Know
Avantor AVTR released its Q4 earnings on Friday, February 7, 2025 at 06:05 AM. Here's what's important from the earnings announcement. Avantor beat estimated earnings by 4.0%, reporting an EPS of $0.27 versus an estimate of $0.26.
Zacks Research Estimates Avantor’s Q1 Earnings (NYSE:AVTR)
Analysts at Zacks Research reduced their Q1 2025 earnings per share estimates for Avantor in a research report issued to clients and investors on Wednesday, February 5th. Zacks Research analyst D. Dey now forecasts that the company will post earnings of $0.
Avantor Earnings: What To Look For From AVTR
There has been positive sentiment among investors in the research tools & consumables segment, with share prices up 2.3% on average over the last month. Avantor is down 2.6% during the same time and is heading into earnings with an average analyst price target of $26.37 (compared to the current share price of $21.55).
Avantor, Inc Q4 Profit Increases, Beats Estimates
Avantor, Inc (AVTR) released a profit for its fourth quarter that increased from the same period last year and beat the Street
Avantor (AVTR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended December 2024, Avantor, Inc. (AVTR) reported revenue of $1.69 billion, down 2.1% over the same period last year. EPS came in at $0.27, compared to $0.25 in the year-ago quarter.
Avantor reports Q4 earnings beat, revenue miss
NEW YORK - Avantor, Inc. (NYSE:AVTR), a provider of mission-critical products and services to life sciences and advanced technology industries, reported fourth-quarter 2024 results on Friday that beat earnings expectations but fell short on revenue.
Avantor Full Year 2024 Earnings: EPS Beats Expectations
Full Year 2024 Results Key Financial Results Revenue: US$6.78b (down 2.6% from FY 2023).
Hosted on MSN1d
Why Avantor (AVTR) Stock Is Trading Lower Today
What Happened? Shares of life sciences company Avantor (NYSE:AVTR) fell 9.4% in the afternoon session after the company ...
Avantor signals 2025 growth with mid-to-high single-digit bioprocessing projections and $300M cost savings target
Q4 2024 Management View Michael Stubblefield, CEO, highlighted Avantor's return to growth in Q4 2024 with low single-digit organic growth and strong bioprocessing performance, achieving high ...
Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025
Avantor's Q4 net sales missed estimates, but adjusted EPS beat expectations. The company projects 2025 organic revenue growth ...
Avantor reports Q4 adjusted EPS 27c, consensus 26c
Reports Q4 revenue $1.69B, consensus $1.71B. “Our fourth quarter results highlight our team’s commitment to commercial intensity, operational ...
Avantor 4Q Sales Slips on Forex, Profit Jumps on Asset Sale
Avantor recorded slightly lower sales in its fourth quarter due to unfavorable foreign exchange rates, though its earnings were boosted by a divestiture. The biopharma supplier posted a profit of $500 ...